ARL2-SNX15

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, ARL2-SNX15 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated ARL2-SNX15 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher ARL2-SNX15 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ARL2-SNX15 expression acts as an unfavorable survival marker, although some lineages such as COAD and UVM show a favorable association.

KIRC, COAD, and LUSC are the cancer types where ARL2-SNX15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRCOSQuartileAll0.4330.664<.00179view →
COADDFSTertileAll0.8450.642.00628view →
LUSCDFSMedianII,III,IV0.6280.770.00728view →
BRCAOSQuartileAll0.9450.967.03620view →
UCECOSTertileIII,IV0.7220.839.02618view →
CESCDFSQuartileAll0.3850.654.00416view →
MESOOSMedianII,III,IV0.3050.686.00615view →
HNSCOSTertileIV0.2960.627.00214view →
KICHOSQuartileAll0.8460.980.0099view →
UVMOSMedianII,III,IV0.9710.702.0099view →
DLBCDFSTertileII,III,IV0.4160.878.0219view →
PRADDFSTertileAll0.9290.865.0288view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

ARL2-SNX15–KIRC (OS)

Kaplan–Meier survival curve for ARL2-SNX15 RNA-high vs -low samples in KIRC.

Open the KIRC breakdown →

Exploration